Association Between the hsa-mir-27a Variant and Breast Cancer Risk: A Meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 6207-6210

  Wang, Bin ^a   Ma, Ning ^b,c   Wang, Yajie ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b No 85 Hospital of PLA   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Ethnic groups; Gene polymorphism; Meta analysis

Indexed keywords

MICRORNA;

BREAST TUMOR; CAUCASIAN; GENETIC PREDISPOSITION; HUMAN; META ANALYSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84877038234     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6207     Document Type: Article

References (30)

1. Brennecke J, Hipfner DR, Stark A, et al (2003). Bantam encodes a evelopmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell, 113, 25-36.
2. Catucci I, Verderio P, Pizzamiglio S, et al (2012). The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res Treat, 133, 805-7.
3. Chan JA, Krichevsky AM, Kosik KS (2004). MicroRNA-21 is an antiapoptotic factor n human glioblastoma cells. Cancer Res, 65, 6029-33.
4. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
5. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
6. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
7. Hopper JL (2001). Genetic epidemiology of female breast cancer. Semin Cancer Biol, 11, 367-74.
8. Hu J, Zhou GW, Wang N, et al (2010). MTRR A66G polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 124, 779-84.
9. Hu J, Zhou GW, Wang N, et al (2010). GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 124, 425-31.
10. Kapeller J, Houghton LA, Mönnikes H, et al (2009). First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptortype 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet, 17, 2967-77.
11. Lagos-Quintana M, Rauhut R, Lendeckel W, et al (2001). Identification of novel genes coding for small expressed RNAs. Science, 294, 853-8.
12. Landi D, Gemignani F, Naccarati A, et al (2008). Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis, 29, 579-84.
13. Lau NC, Lim LP, Weinstein EG, et al (2001). An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans. Science, 294, 858-62. Le Quesne J, Caldas C (2010). Micro-RNAs and breast cancer. Mol Oncol, 4, 230-41.
14. Le Quesne J, Caldas C (2010). Micro-RNAs and breast cancer. Mol Oncol, 4, 230-41.
15. Lee RC, Ambros V (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science, 294, 862-4.
16. Li X, Mertens-Talcott SU, Zhang S, Kim K, et al (2010) .MicroRNA-27a indirectly regulates estrogen receptor a expression and hormone responsiveness in MCF-7 breast cancer cells. Endocrinology, 151, 2462-73.
17. Ma Y, Yu S, Zhao W, et al (2010). miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Letters, 298, 150-8.
18. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
19. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S (2007). The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Research, 67, 11001-11.
20. Narod SA (2002). Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer, 2, 113-23.
21. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
22. Pharoah PD, Antoniou A, Bobrow M, et al (2002). Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet, 31, 33-6.
23. Porkka KP, Pfeiffer MJ, Waltering KK, et al (2007). MicroRNA expression profiling in prostate cancer. Cancer Res, 67, 6130-5.
24. Ryan BM, Robles AI, Harris CC (2010). Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancerb, 10, 389-402.
25. Sun Q, Gu H, Zeng Y, et al (2010). Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci, 101, 2241-7.
26. Tchatchou S, Jung A, Hemminki K, et al (2009). A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis, 30, 59-64.
27. Tran N, McLean T, Zhang X, et al (2007). MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun, 358, 12-7.
28. Volinia S, Calin GA, Liu CG, et al (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA, 103, 2257-61.
29. Yang R, Schlehe B, Hemminki K, et al (2010). A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat, 121, 693-702.
30. Zhang M, Jin M, Yu Y, et al (2012). Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care, 21, 274-80.